Opening book details…
About this Medicine article
Crohn's disease outpatients treated with adalimumab have an earlier secondary loss of response and requirement for dose escalation compared to infliximab: A real life cohort study by Ma, Christopher; Huang, Vivian; Fedorak, Darryl K.; Kroeker, Karen I.; Dieleman, Levinus A.; Halloran, Brendan P.; Fedorak, Richard N. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Ma, Christopher; Huang, Vivian; Fedorak, Darryl K.; Kroeker, Karen I.; Dieleman, Levinus A.; Halloran, Brendan P.; Fedorak, Richard N.
- Publisher
- Oxford University Press; Oxford University Press (OUP) (ISSN 1873-9946)
- Published
- 2014
- Field
- Medicine (Health Sciences)